Topoisomerase II as a Novel Antiviral Target against Panarenaviral Diseases
Although many arenaviruses cause severe diseases with high fatality rates each year, treatment options are limited to off-label use of ribavirin, and a Food and Drug Administration (FDA)-approved vaccine is not available. To identify novel therapeutic candidates against arenaviral diseases, an RNA p...
Main Authors: | Tosin Oladipo Afowowe, Yasuteru Sakurai, Shuzo Urata, Vahid Rajabali Zadeh, Jiro Yasuda |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/15/1/105 |
Similar Items
-
Potential and action mechanism of favipiravir as an antiviral against Junin virus.
by: Vahid Rajabali Zadeh, et al.
Published: (2022-07-01) -
Molecular Mechanism of Arenavirus Assembly and Budding
by: Shuzo Urata, et al.
Published: (2012-10-01) -
The African Swine Fever Virus (ASFV) Topoisomerase II as a Target for Viral Prevention and Control
by: João Coelho, et al.
Published: (2020-06-01) -
M Segment-Based Minigenome System of Severe Fever with Thrombocytopenia Syndrome Virus as a Tool for Antiviral Drug Screening
by: Hiroshi Yamada, et al.
Published: (2021-06-01) -
Actions of a Novel Bacterial Topoisomerase Inhibitor against <i>Neisseria gonorrhoeae</i> Gyrase and Topoisomerase IV: Enhancement of Double-Stranded DNA Breaks
by: Soziema E. Dauda, et al.
Published: (2023-07-01)